Study of Azacitidine in Combination With Pembrolizumab in R/R AML Patients and in Newly Diagnosed Older Patients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Economic Analysis of Blood Product Transfusions According to the Treatment of Acute Myeloid Leukaemia in the Elderly
- Status
- COMPLETED
- Phase
- N/A
Effect of Age on Treatment Decision-Making in Elderly Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- N/A
A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- N/A
A Study of Indoximod in Combination With (7+3) Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1
Microtransplantation in Older Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Biomarker-Directed Phase 2 Trial of Tamibarotene (SY-1425) in Participants With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
FLYSYN in MRD Positive AML
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Vadastuximab Talirine (SGN-CD33A; 33A) Combined With Azacitidine or Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE3
Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Home Away From Home - Medical Outcomes
- Status
- COMPLETED
- Phase
- N/A
Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in AML Patient Not Eligible for Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery
- Status
- COMPLETED
- Phase
- N/A